Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (30782)	8/4/2017 8:51:15 AM
From: Goose94	Read Replies (1) \| Respond to of 203329

Marijuana Life Sciences Index ETF (HMMJ-T) the $120-million (U.S.) Horizons Marijuana Life Sciences ETF -- the first exchange-traded fund in North America that focuses on the legal weed market -- launched in April in Toronto. No U.S. rivals, as U.S. federal law prohibits the drug, making it difficult to set up a fund. With positions including pot grower Aurora Cannabis, medical weed firms such as GW Pharmaceuticals and fertilizer company Scotts Miracle-Gro, the fund attempts to capture the full extent of the Canadian pot industry, which Deloitte expects could grow to $22.6-billion if the recent bill to legalize recreational use is successful. Horizon co-chief executive officer Steve Hawkins says: "We expect to add new constituents with every quarterly rebalance. With the full legalization news in Canada, there's a lot of strong growth prospects for this industry." He notes: "More than 95 per cent of the fund unit owners are Canadian. It's very difficult for Americans to trade Canadian ETFs." Mr. Hawkins says the ETF has a sister company in the U.S. and he is pondering what it would take to list in the U.S.